The company posted sales of EUR97 million for January-September 2012.
In Romania, Gedeon Richter operates a medical drug production unit (Gedeon Richter Romania) in Targu-Mures, a network of over 120 drugstores (Gedeon Richter Farmacia) and wholesaler Pharmafarm.
The distribution and retail segments registered sales of EUR94.2 million in the analyzed interval, up 13.5% on the year.
Gedeon Richter’s sales in Romania rose 1.4% on the year to EUR131.4 million in 2012. Its Romanian operations generated over 11% of the group’s total turnover, of EUR1.13 billion.
The group expects sales in Romania to remain steady or increase by 5% in 2013. Gedeon Richter was the 20th largest pharmaceutical company in Romania last year with a market share of 1.4%, according to market research company Cegedim.
Gedeon Richter has invested over $50 million in Romania since 1998, when it bought medical drug producer Armedica in Targu Mures. Investments targeted new production units, quality control labs, product development and a logistics center.
Gedeon Richter registered 5.2% higher sales worldwide in the first nine months, of EUR878.5 million.